Pidogrel Plus is a combination antiplatelet medication containing 75 mg of clopidogrel bisulfate and 75 mg of aspirin per tablet. Manufactured by Radiant Pharmaceuticals Ltd., this formulation is designed to reduce the risk of thrombotic cardiovascular events such as myocardial infarction (heart attack) and stroke in patients with acute coronary syndrome (ACS), including both non-ST elevation (NSTEMI) and ST elevation (STEMI) myocardial infarction. It is also indicated for patients with a history of recent myocardial infarction, stroke, or established peripheral arterial disease to decrease the occurrence of these events